Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC39169
CC-92480
CC-92480
A modulator of cereblon - GC39167 VBIT-4 VBIT-4 is a voltage-dependent anion channel (VDAC) oligomerization inhibitor that decreases mitochondrial DNA (mtDNA) release, type I interferon (IFN) signaling, neutrophil extracellular traps, and disease severity in a mouse model of systemic lupus erythematosus.
- GC39155 PI-273 PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
-
GC39152
9-ING-41
Elraglusib
A GSK3β inhibitor -
GC39135
Ranaconitine
7-羟基高乌甲素
An alkaloid with analgesic and anesthetic activities - GC39094 Thonningianin A Thonningianin A 是一种鞣花素,从非洲草药通宁宁的甲醇提取物中分离得到。Thonningianin A 的抗氧化特性包括自由基清除、抗超氧物生成和金属螯合作用。具有抗癌活性。
-
GC39070
Negletein
黄芩素-7-甲醚; 5,6-Dihydroxy-7-methoxyflavone
Negletein 是一种神经保护剂,可增强神经生长因子的作用并诱导 PC12 细胞中的神经突向外生长。Negletein 通过抑制 TNF-α 和 IL-1β 表现出有希望的抗炎活性,其 IC50 值分别为 16.4 和 10.8 μM。 -
GC39069
Poncirin
枸橘甙
A flavonoid glycoside with diverse biological activities -
GC39063
Prosapogenin A
重楼皂苷E,Progenin III
Prosapogenin A 是藜芦中的天然产物,通过抑制 STAT3 信号通路和糖酵解,在体外诱导人癌细胞凋亡。 -
GC39062
Kumatakenin
熊竹素
A flavonoid with diverse biological activities -
GC39041
Polyporenic acid C
聚孔酸C
Polyporenic acid C 是从 P. cocos 中分离出的羊毛甾烷型三萜。Polyporenic acid C 通过死亡受体介导的凋亡途径诱导细胞凋亡 (apoptosis),而无需线粒体的参与。 Polyporenic acid C 是治疗肺癌的有前途的药物。 -
GC39040
Taraxerol acetate
醋酸蒲公英霜
Taraxerol acetate 是 COX-1 和 COX-2 抑制剂, IC50 值分别为 116.3 μM 和 94.7μM。Taraxerol acetate 具有抗癌作用并诱导细胞凋亡(apoptosis)。 -
GC39022
Tetramethylcurcumin
四甲基姜黄素; FLLL31
Tetramethylcurcumin (FLLL31), a small-molecule signal transducer and activator of transcription 3 (STAT3) inhibitor derived from curcumin, binds selectively to Janus kinase 2 and the STAT3 Src homology-2 domain, which serve crucial roles in STAT3 dimerization and signal transduction. -
GC38973
Osmundacetone
紫萁酮
Osmundacetone 是从 Osmundae Rhizoma 中分离出的一种天然产物。 -
GC38970
Sophoraflavanone G
槐黄烷酮G,Kushenol F
A flavonoid with diverse biological activities -
GC38969
Neogambogic acid
新藤黄酸
Neogambogic acid 是藤黄的有效成分,可诱导细胞凋亡并具有抗癌作用。 Neogambogic acid 对耐甲氧西林的金黄色葡萄球菌 (MRSA) 具有明显的抑制活性。 -
GC38967
Lycorine
石蒜碱
An alkaloid with diverse biological activities - GC38943 PROTAC Mcl1 degrader-1 PROTAC Mcl1 degrader-1 (compound C3) 是一种靶向嵌合体的蛋白水解 (PROTAC),是有效,选择性的 Mcl-1 抑制剂,IC50 为 0.7 μM。PROTAC Mcl1 degrader-1 通过将具有微摩尔范围亲和力的 E3 连接酶脑 (CRBN) 结合配体 pomalidomide 引入 Mcl-1 抑制剂 S1-6 来诱导 Mcl-1 的泛素化和蛋白酶体降解。
- GC38941 PROTAC Bcl2 degrader-1 PROTAC Bcl2 degrader-1 (Compound C5) 是一种 PROTAC,通过将 E3 连接酶 cereblon 的配体 pomalidomide 引入到 Mcl-1/Bcl-2 的双重抑制剂 Nap-1,来有效、特异性地诱导 Bcl-2 (IC50,4.94 μM;DC50,3.0 μM) 和 Mcl-1 (IC50,11.81 μM) 的降解。
- GC38928 MCL-1/BCL-2-IN-3 MCL-1/BCL-2-IN-3 (Compound 2) 是一种有效的选择性 Mcl-1 和 Bcl-2 抑制剂,IC50 分别为 5.95 和 4.78 μM。
- GC38927 MCL-1/BCL-2-IN-2 MCL-1/BCL-2-IN-2 (Compound 6) 是一种有效的选择性 Mcl-1 和 Bcl-2 抑制剂。
-
GC46031
Malabaricone B
NSC 287967, NSC 630196
A diarylnonanoid with diverse biological activities -
GC46028
Malabaricone C
马拉巴酮C
A diarylnonanoid with diverse biological activities -
GC46027
IP7e
Isoxazolo-pyridinone 7e
An activator of Nurr1 signaling - GC46020 Stachybotrysin B A fungal metabolite with antiviral and anticancer activities
- GC46015 KY 05009 A TNIK inhibitor
-
GC46008
(±)-Thalidomide-d4
沙利度胺 D4
An internal standard for the quantification of (±)-thalidomide - GC46006 Terpendole I A fungal metabolite
-
GC45992
Diallyl Tetrasulfide
二烯丙基四硫醚,ICD-1585
An organosulfur compound with diverse biological activities -
GC45965
Tolfenamic Acid-d4
托芬那酸 D4
An internal standard for the quantification of tolfenamic acid -
GC45960
9c(i472)
15-LOX-1 Inhibitor i472
A 15-LO-1 inhibitor -
GC45944
para-amino-Blebbistatin
(–)-4'-amino-Blebbistatin, p-amino-Blebbistatin, (S)-4'-amino-Blebbistatin
A more stable and less phototoxic form of (–)-blebbistatin with enhanced water solubility - GC38868 TRAF-STOP inhibitor 6877002 TRAF-STOP inhibitor 6877002是一种抑制CD40-TRAF6相互作用的选择性抑制剂(TRAF-STOPs)。
- GC38864 TL02-59 TL02-59 is an orally active, selective Src-family kinase Fgr inhibitor with an IC50 of 0.03 nM.
- GC38863 TK216 TK216 is a potent inhibitor targeting E26 transformation specific (ETS) factors via blocking the protein-protein interaction with RNA helicases. TK216 exhibits antilymphoma activity.
-
GC38853
Tandutinib hydrochloride
MLN518 hydrochloride; CT53518 hydrochloride
An antagonist of PDGFRβ, FLT3, and c-Kit -
GC38848
Se-Methylselenocysteine
L-硒甲基硒代半胱氨酸,Methylselenocysteine; Se-Methylseleno-L-cysteine
A selenium-containing amino acid - GC38841 RIPK1-IN-4 RIPK1-IN-4 (compound 8) 是一种有效的 II 型激酶受体相互作用蛋白1 (RIP1) 激酶抑制剂,并且与 DL1-out 无活性形式的 RIP1 结合,对于 RIP1 和 ADP-Glo 激酶,IC50 为分别为 16 nM 和 10 nM。
-
GC38819
ML334
LH601A
ML334是一种有效的NRF2细胞渗透性激活剂。 -
GC38817
Minerval
2-羟基乳清酸,2-Hydroxyoleic acid; 2-OHOA
A synthetic monounsaturated hydroxylated fatty acid
- GC38812 MD-224 MD-224 是基于蛋白水解定位嵌合体 (PROTAC) 的高效小分子 (MDM2) 降解物。MD-224 在人白血病细胞中,诱导 MDM2 的快速降解 (<1 nM),抑制 RS4;11 细胞生长的 IC50 值为 1.5 nM。MD-224 有可能成为一类新的抗癌剂。
- GC38811 Mcl1-IN-8 Mcl1-IN-8 (Compound 8) 是一种具有口服活性的 Mcl-1-PUMA 界面抑制剂,Ki 为 0.3 μM. Mcl1-IN-8 在减少 PUMA 依赖性细胞凋亡方面表现出双重活性,同时在癌细胞中失活 Mcl-1 介导的抗细胞凋亡。
-
GC38772
DIM-C-pPhOH
4(二(1H-吲哚-3-基)甲基)苯酚
A Nur77 antagonist - GC38740 BMS-1001 hydrochloride An inhibitor of the PD-1/PD-L1 interaction
- GC45894 Daunorubicin-13C-d3 A neuropeptide with diverse biological activities
-
GC45829
Troglitazone-d4
CS-045-d4
Troglitazone-d4 是氘标记的曲格列酮。 Troglitazone 是一种 PPARγ 激动剂,对人和鼠 PPARγ 受体的 EC50 分别为 550 nM 和 780 nM。 - GC45801 Hesperetin-13C-d3 A neuropeptide with diverse biological activities
-
GC45800
Cytarabine-13C3
Ara-C-13C3, 1-β-D-Arabinofuranosylcytosine-13C3
A neuropeptide with diverse biological activities -
GC45798
Rhein-13C4
1,8-二羟基-3-羧基蒽醌
An internal standard for the quantification of rhein
-
GC45772
6(5H)-Phenanthridinone
6(5H)-菲啶酮
An inhibitor of PARP1 and 2